The Cigna Group (CI) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $10.41B; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $10.41B | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $10.41B |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 114.17B USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities · Commercial Paper |
| Amounts owed to suppliers | 10.41B USD | Accounts Payable, Current |
| Total deferred revenue | (m) | |
| Deferred revenue due within one year | (m) | |
| Deferred revenue due after one year | (m) | |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | 5.61B USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Obligation categories | (m) |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $10.41B | (m) | (m) | (m) | $114.17B | (m) | (m) | (m) | $5.61B | (m) |
| 2026-03-31 | (m) | $9.88B | (m) | (m) | (m) | $110.82B | (m) | (m) | (m) | $4.77B | (m) |
| 2025-12-31 | (m) | $10.66B | (m) | (m) | (m) | $116.05B | (m) | (m) | (m) | $4.24B | (m) |
| 2025-09-30 | (m) | $9.35B | (m) | (m) | (m) | $115.91B | (m) | (m) | (m) | $3.87B | (m) |
| 2025-06-30 | (m) | $9.94B | (m) | (m) | (m) | $111.22B | (m) | (m) | (m) | $3.65B | (m) |
| 2025-03-31 | (m) | $9.14B | (m) | (m) | (m) | $110.24B | (m) | (m) | (m) | $3.58B | (m) |
| 2024-12-31 | (m) | $9.29B | (m) | (m) | (m) | $114.64B | (m) | (m) | (m) | $3.21B | (m) |
| 2024-09-30 | (m) | $8.52B | (m) | (m) | (m) | $115.34B | (m) | (m) | (m) | $3.03B | (m) |
| 2024-06-30 | (m) | $9.28B | (m) | (m) | (m) | $113.92B | (m) | (m) | (m) | $3.54B | (m) |
| 2024-03-31 | (m) | $8.12B | (m) | (m) | (m) | $111.77B | (m) | (m) | (m) | $3.65B | (m) |
| 2023-12-31 | (m) | $8.55B | (m) | (m) | (m) | $106.41B | (m) | (m) | (m) | $3.44B | (m) |
| 2023-09-30 | (m) | $7.67B | (m) | (m) | (m) | $103.88B | (m) | (m) | (m) | $2.93B | (m) |
| 2023-06-30 | (m) | $8.07B | (m) | (m) | (m) | $104.53B | (m) | (m) | (m) | $2.58B | (m) |
| 2023-03-31 | (m) | $7.36B | (m) | (m) | (m) | $103.38B | (m) | (m) | (m) | $2.69B | (m) |
| 2022-12-31 | (m) | $7.78B | (m) | (m) | (m) | $98.98B | (m) | (m) | (m) | $3.14B | (m) |
| 2022-09-30 | (m) | $6.87B | (m) | (m) | (m) | $99.08B | (m) | (m) | (m) | $3.18B | (m) |
| 2022-06-30 | (m) | $7.14B | (m) | (m) | (m) | $106.66B | (m) | (m) | (m) | $3.17B | (m) |
| 2022-03-31 | (m) | $6.63B | (m) | (m) | (m) | $106.45B | (m) | (m) | (m) | $3.35B | (m) |
| 2021-12-31 | (m) | $6.66B | (m) | (m) | (m) | $107.70B | (m) | (m) | (m) | $3.76B | (m) |
| 2021-09-30 | (m) | $5.66B | (m) | (m) | (m) | $106.77B | (m) | (m) | (m) | $4.26B | (m) |
| 2021-06-30 | (m) | $5.65B | (m) | (m) | (m) | $105.44B | (m) | (m) | (m) | $4.33B | (m) |
| 2021-03-31 | (m) | $5.64B | (m) | (m) | (m) | $103.87B | (m) | (m) | (m) | $4.49B | (m) |
| 2020-12-31 | (m) | $5.48B | (m) | (m) | (m) | $105.06B | (m) | (m) | (m) | $4.63B | (m) |
| 2020-09-30 | (m) | $5.33B | (m) | (m) | (m) | $111.95B | (m) | (m) | (m) | $4.55B | (m) |
| 2020-06-30 | (m) | $5.41B | (m) | (m) | (m) | $112.22B | (m) | (m) | (m) | $4.78B | (m) |
| 2020-03-31 | (m) | $5.58B | (m) | (m) | (m) | $109.59B | (m) | (m) | (m) | $4.52B | (m) |
| 2019-12-31 | (m) | $5.09B | (m) | (m) | (m) | $110.39B | (m) | (m) | (m) | $4.46B | (m) |
| 2019-09-30 | (m) | $4.50B | (m) | (m) | (m) | $110.11B | (m) | (m) | (m) | $3.92B | (m) |
| 2019-06-30 | (m) | $4.52B | (m) | (m) | (m) | $110.55B | (m) | (m) | (m) | $3.93B | (m) |
| 2019-03-31 | (m) | $4.49B | (m) | (m) | (m) | $111.90B | (m) | (m) | (m) | $3.83B | (m) |
| 2018-12-31 | (m) | $4.37B | (m) | (m) | (m) | $112.15B | (m) | (m) | (m) | $3.47B | (m) |
| 2017-12-31 | (m) | $184.00M | (m) | (m) | (m) | $48.00B | (m) | (m) | (m) | $2.84B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |